Total Payments
$5,209
2024 Payments
$1,454
Companies
5
Transactions
23
Medicare Patients
936
Medicare Billing
$72,778
Payment Breakdown by Category
Consulting$2,500 (48.0%)
Travel$2,168 (41.6%)
Food & Beverage$500.84 (9.6%)
Education$40.05 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,500 | 1 | 48.0% |
| Travel and Lodging | $2,168 | 9 | 41.6% |
| Food and Beverage | $500.84 | 12 | 9.6% |
| Education | $40.05 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AMAG Pharmaceuticals, Inc. | $3,688 | 6 | $0 (2017) |
| Eli Lilly and Company | $1,454 | 14 | $0 (2024) |
| MILLICENT US INC | $40.05 | 1 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $14.68 | 1 | $0 (2023) |
| AbbVie Inc. | $11.82 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,454 | 14 | Eli Lilly and Company ($1,454) |
| 2023 | $14.68 | 1 | Teva Pharmaceuticals USA, Inc. ($14.68) |
| 2021 | $40.05 | 1 | MILLICENT US INC ($40.05) |
| 2020 | $11.82 | 1 | AbbVie Inc. ($11.82) |
| 2017 | $3,688 | 6 | AMAG Pharmaceuticals, Inc. ($3,688) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/17/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $339.00 | General |
| 06/17/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $320.00 | General |
| 06/17/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $118.73 | General |
| 06/17/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $51.79 | General |
| 06/17/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $51.01 | General |
| 06/17/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $42.98 | General |
| 06/17/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $32.96 | General |
| 06/17/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $32.96 | General |
| 06/17/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $32.00 | General |
| 06/17/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $15.00 | General |
| 06/17/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $14.12 | General |
| 06/17/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $14.12 | General |
| 06/16/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $217.20 | General |
| 06/16/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $171.97 | General |
| 06/13/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Central Nervous System | ||||||
| 04/07/2021 | MILLICENT US INC | FEMRING (Drug) | Education | In-kind items and services | $40.05 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 11/04/2020 | AbbVie Inc. | LO LOESTRIN FE (Drug), ORILISSA | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: WOMENS HEALTH | ||||||
| 09/08/2017 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: INTRAROSA | ||||||
| 09/08/2017 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Travel and Lodging | Cash or cash equivalent | $629.48 | General |
| Category: INTRAROSA | ||||||
| 09/08/2017 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Travel and Lodging | Cash or cash equivalent | $400.24 | General |
| Category: INTRAROSA | ||||||
| 09/08/2017 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $79.51 | General |
| Category: INTRAROSA | ||||||
| 09/08/2017 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $46.55 | General |
| Category: INTRAROSA | ||||||
| 09/08/2017 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $32.59 | General |
| Category: INTRAROSA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 365 | 428 | $251,670 | $31,838 |
| 2022 | 9 | 240 | 288 | $132,709 | $16,310 |
| 2021 | 7 | 209 | 260 | $80,968 | $16,570 |
| 2020 | 5 | 122 | 158 | $36,417 | $8,060 |
Total Patients
936
Total Services
1,134
Medicare Billing
$72,778
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 59 | 66 | $55,368 | $6,746 | 12.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 91 | $53,955 | $6,579 | 12.2% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 60 | 67 | $49,329 | $6,368 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 46 | $38,643 | $4,765 | 12.3% |
| 93976 | Ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 19 | 21 | $22,135 | $2,636 | 11.9% |
| 56605 | Biopsy of growth of external female genitals, first growth | Office | 2023 | 14 | 15 | $9,629 | $1,244 | 12.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 23 | $8,590 | $1,062 | 12.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 24 | 24 | $6,255 | $1,049 | 16.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 20 | 20 | $5,950 | $981.80 | 16.5% |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | Office | 2023 | 11 | 13 | $832.00 | $220.48 | 26.5% |
| 87210 | Smear for infectious agents | Office | 2023 | 19 | 19 | $570.00 | $108.30 | 19.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 16 | 23 | $414.00 | $78.43 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 77 | $46,165 | $5,086 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 32 | $27,010 | $3,150 | 11.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 45 | 60 | $22,628 | $2,855 | 12.6% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 14 | 16 | $12,005 | $1,552 | 12.9% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 11 | 13 | $11,050 | $1,389 | 12.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 27 | 27 | $7,101 | $1,117 | 15.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 19 | 19 | $5,586 | $943.73 | 16.9% |
| 87210 | Smear for infectious agents | Office | 2022 | 26 | 31 | $930.00 | $179.10 | 19.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 13 | $234.00 | $38.78 | 16.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 50 | $26,978 | $5,596 | 20.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 65 | $28,575 | $4,829 | 16.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 12 | $7,468 | $1,951 | 26.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 30 | 37 | $8,068 | $1,795 | 22.3% |
About Dr. Nancy Phillips, MD
Dr. Nancy Phillips, MD is a Gynecology healthcare provider based in New Brunswick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1326166307.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nancy Phillips, MD has received a total of $5,209 in payments from pharmaceutical and medical device companies, with $1,454 received in 2024. These payments were reported across 23 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($2,500).
As a Medicare-enrolled provider, Phillips has provided services to 936 Medicare beneficiaries, totaling 1,134 services with total Medicare billing of $72,778. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Other Specialties Gynecology
- Location New Brunswick, NJ
- Active Since 03/27/2007
- Last Updated 07/23/2021
- Taxonomy Code 207VG0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326166307
Products in Payments
- INTRAROSA (Drug) $3,688
- FEMRING (Drug) $40.05
- Austedo XR (Drug) $14.68
- LO LOESTRIN FE (Drug) $11.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.